As of 2025-09-15, the Intrinsic Value of Landos Biopharma Inc (LABP) is -39.61 USD. This LABP valuation is based on the model Peter Lynch Fair Value. With the current market price of 22.93 USD, the upside of Landos Biopharma Inc is -272.74%.
Based on its market price of 22.93 USD and our intrinsic valuation, Landos Biopharma Inc (LABP) is overvalued by 272.74%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -39.61 - -39.61 | -39.61 | -272.74% |
| P/E | (71.14) - (99.82) | (97.84) | -526.7% |
| DDM - Stable | (65.04) - (193.48) | (129.26) | -663.7% |
| DDM - Multi | (50.89) - (119.98) | (71.73) | -412.8% |
| Market Cap (mil) | 71.77 |
| Beta | 0.70 |
| Outstanding shares (mil) | 3.13 |
| Enterprise Value (mil) | 42.77 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.90% |
| Cost of Debt | 5.00% |
| WACC | 6.78% |